Dr Peter Addy

Dr. Peter Addy, psychotherapist, is a licensed professional counselor who provides psychedelic integration and harm reduction therapy at his private practice while training psilocybin facilitators in Oregon’s approved program. After conducting psychedelic research at Yale School of Medicine and co-founding the Yale Psychedelic Science Group, he transitioned into clinical practice. Grounding his work in principles of harm reduction and transpersonal psychology, Dr. Addy skillfully supports clients who use psychedelics. His therapy and teaching approach encourages dismantling systems of oppression and inspiring radical compassion. Passionate about equitable access, he wants to empower all people to explore their inner worlds safely.

Centres d'intérêts

Recherche clinique sur les psychédéliques et états modifiés de conscience (ex : Salvia divinorum, cannabinoïdes, THC)

Approches de réduction des risques et intégration thérapeutique des expériences psychédéliques dans la pratique de la psychothérapie

Traitement de la douleur chronique par des approches alternatives et intégratives

Présence sur internet

https://peterhaddy.com/

https://scholar.google.com/citations?user=k-_aeLIAAAAJ&hl=en

https://www.linkedin.com/in/peterhaddy

Quelques publications

• Ranganathan, M., Radhakrishnan, R., Addy, P. H., Schnakenberg-Martin, A. M., Williams, A. H., Carbuto, M., et al. (2017). Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 79(Part B), 176–183. https://doi.org/10.1016/j.pnpbp.2017.06.019
• García-Romeu, A., Kersgaard, B., & Addy, P. H. (2016). Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology, 24(4), 229–268. https://doi.org/10.1037/pha0000084
• Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., et al. (2016). Naltrexone but not ketanserin antagonizes the subjective, cardiovascular, and neuroendocrine effects of salvinorin-A in humans. The International Journal of Neuropsychopharmacology, 19(3), pyw016. https://doi.org/10.1093/ijnp/pyw016
• Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., et al. (2015). Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology, 18(12), pyv065. https://doi.org/10.1093/ijnp/pyv065
• Addy, P. H., García-Romeu, A., Metzger, M., & Wade, J. (2015). The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology, 29(4), 426–435. https://doi.org/10.1177/0269881115570081

Affiliations

• Clinicien-psychologue privé (Portland, Oregon) spécialisé dans la thérapie assistée par psychédéliques et la réduction des risques
• Ancien chercheur en psychologie clinique et en psychopharmacologie, affilié à Yale University, Centre pour l'informatique médicale (Yale Center for Medical Informatics)